E-LIB Suche - Ergebnisse für: Castagnetti, F.

1

Treatment discontinuation following low-dose TKIs in 248 ch..:

Iurlo, A ; Cattaneo, D ; Consonni, D...
info:eu-repo/semantics/altIdentifier/pmid/37033642. , 2023

Link: https://hdl.handle.net/1..

2

Treatment discontinuation following low-dose TKIs in 248 ch..:

Iurlo, A ; Cattaneo, D ; Consonni, D...
info:eu-repo/semantics/altIdentifier/pmid/37033642. , 2023

Link: https://hdl.handle.net/2..

3

IL-18 and VEGF-A trigger type 2 innate lymphoid cell accumu..:

Fiordi, B ; Salvestrini, V ; Gugliotta, G...
info:eu-repo/semantics/altIdentifier/doi/10.3324/haematol.2022.282140. , 2023

Link: https://serval.unil.ch/n..

4

Treatment discontinuation following low-dose TKIs in 248 ch..:

Iurlo, A ; Cattaneo, D ; Consonni, D...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076530/. , 2023

Link: http://www.ncbi.nlm.nih...

5

Efficacy and safety of nilotinib as frontline treatment in ..:

Luciano L ; Latagliata R ; Gugliotta G...
info:eu-repo/semantics/altIdentifier/pmid/37079069. , 2023

Link: https://hdl.handle.net/1..

6

Treatment-Free Remission in Chronic Myeloid Leukemia Patien..:

Iurlo A ; Cattaneo D ; Artuso S...
info:eu-repo/semantics/altIdentifier/pmid/35311109. , 2022

Link: http://hdl.handle.net/23..

7

COVID-19 infection in chronic myeloid leukaemia after one y..:

Breccia M ; Abruzzese E ; Accurso V...
info:eu-repo/semantics/altIdentifier/pmid/34636033. , 2022

Link: http://hdl.handle.net/11..

8

Dihydroorotate dehydrogenase inhibition reveals metabolic v..:

Houshmand M ; Vitale N ; Orso F...
info:eu-repo/semantics/altIdentifier/pmid/35773274. , 2022

Link: https://hdl.handle.net/1..

9

Treatment-free remission in chronic myeloid leukemia patien..:

Gugliotta G ; Castagnetti F ; Breccia M...
info:eu-repo/semantics/altIdentifier/wos/WOS:000870533100011. , 2022

Link: https://hdl.handle.net/1..

10

Treatment-Free Remission in Chronic Myeloid Leukemia Patien..:

Iurlo A ; Cattaneo D ; Artuso S...
info:eu-repo/semantics/altIdentifier/pmid/35311109. , 2022

Link: https://hdl.handle.net/1..

11

Treatment-Free Remission in Chronic Myeloid Leukemia Patien..:

Iurlo A ; Cattaneo D ; Artuso S...
volume:12. , 2022

Link: http://hdl.handle.net/11..

12

P1706: CLINICAL UTILITY OF ONLINE MONITORING OF PATIENT-REP..:

Efficace, F ; Cottone, F ; Yanez, B...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430632/. , 2022

Link: http://www.ncbi.nlm.nih...

13

Questions concerning tyrosine kinase-inhibitor therapy and ..:

Baccarani M ; Bonifazi F ; Soverini S...
info:eu-repo/semantics/altIdentifier/pmid/35338251. , 2022

Link: https://hdl.handle.net/1..

14

Polo-like kinase-1, Aurora kinase A and WEE1 kinase are pro..:

Mancini M ; De Santis S ; Monaldi C...
info:eu-repo/semantics/altIdentifier/pmid/35992847. , 2022

Link: https://hdl.handle.net/1..

15

Dosing Strategies for Improving the Risk-Benefit Profile of..:

Castagnetti F ; Pane F ; Rosti G..
info:eu-repo/semantics/altIdentifier/pmid/33796468. , 2021

Link: http://hdl.handle.net/11..